Survey of the Anxiety Associated With the COVID-19 Pandemic
CORA
Online-based Survey of the Anxiety Associated With the COVID-19 Pandemic in the General Population in Germany
1 other identifier
observational
7,500
1 country
1
Brief Summary
The study aims to systematically examine various aspects of the anxiety associated with the COVID-19 pandemic in Germany. The data collection is carried out online with longitudinal repeated measurements.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for all trials
Started Mar 2020
Typical duration for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
March 27, 2020
CompletedStudy Start
First participant enrolled
March 27, 2020
CompletedFirst Posted
Study publicly available on registry
April 2, 2020
CompletedPrimary Completion
Last participant's last visit for primary outcome
April 1, 2022
CompletedStudy Completion
Last participant's last visit for all outcomes
April 1, 2022
CompletedJanuary 27, 2021
January 1, 2021
2 years
March 27, 2020
January 25, 2021
Conditions
Keywords
Outcome Measures
Primary Outcomes (2)
Characteristics of COVID-19-related anxiety
To investigate specific fears regarding the COVID-19 pandemic 9 self created items are used. Values ranging from 1 to 6, higher scores indicate a worse outcome.
1 day
COVID-19-related anxiety symptoms
Modified German version of the DSM-5 Severity-Measure-For-Specific-Phobia-Adult-Scale by Beesdo-Baum et al. (2014). 10 items, values ranging from 1 to 5, higher scores indicate a worse outcome. The Scale was adapted to anxiety symptoms related to COVID-19.
1 day
Secondary Outcomes (7)
Self-efficacy and coping with COVID-19
baseline (1 day) + after 3 weeks + after 6 weeks + after 9 weeks + after 6 months + after 7 months + after 9 months + after 12 months
Consequences of COVID-19 in the last three weeks.
baseline (1 day) + after 3 weeks + after 6 weeks + after 9 weeks + after 6 months + after 7 months + after 9 months + after 12 months
General Illness Attitude
baseline (1 day) + after 3 weeks + after 6 weeks + after 9 weeks + after 6 months + after 7 months + after 9 months + after 12 months
Media reporting
baseline (1 day) + after 3 weeks + after 6 weeks + after 9 weeks + after 6 months + after 7 months + after 9 months + after 12 months
Ultra-brief screening scale for anxiety and depression
baseline (1 day) + after 3 weeks + after 6 weeks + after 9 weeks + after 6 months + after 7 months + after 9 months + after 12 months
- +2 more secondary outcomes
Study Arms (1)
Population in Germany
Reasonably large and representative sample of the general population in Germany
Interventions
Eligibility Criteria
General population in Germany
You may qualify if:
- informed consent was given
- age ≥ 18
- able to complete the questionnaire in German
- country of residence: Germany
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Charité-Universitätsmedizin Berlin - Department of Psychiatry and Psychotherapy
Berlin, 10117, Germany
Related Publications (3)
Bendau A, Petzold MB, Strohle A, Plag J. Viral Transmission? A Longitudinal Study of Media Use and Its Relation to Mental Strain During the First 2 Years of the COVID-19 Pandemic. Int J Behav Med. 2025 Apr;32(2):214-226. doi: 10.1007/s12529-024-10293-3. Epub 2024 May 20.
PMID: 38769221DERIVEDBendau A, Petzold MB, Plag J, Asselmann E, Strohle A. Illness anxiety predicts higher mental strain and vaccine willingness-A nine-wave longitudinal study during the first 1.5 years of the COVID-19 pandemic in Germany. Stress Health. 2023 Dec;39(5):1137-1147. doi: 10.1002/smi.3255. Epub 2023 May 9.
PMID: 37158010DERIVEDOlsson A, Olsson M, Fedorowski A, Hagell P, Wictorin K. The Orthostatic Hypotension Questionnaire in Swedish tested in patients with parkinsonism. Brain Behav. 2020 Sep;10(9):e01746. doi: 10.1002/brb3.1746. Epub 2020 Jul 7.
PMID: 32633094DERIVED
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- STUDY DIRECTOR
Andreas Ströhle, Prof.Dr.
Charité-Universitätsmedizin Berlin - Department of Psychiatry and Psychotherapy
- PRINCIPAL INVESTIGATOR
Antonia Bendau, M.Sc.Psych.
Charité-Universitätsmedizin Berlin - Department of Psychiatry and Psychotherapy
Central Study Contacts
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- PROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Principal Investigator
Study Record Dates
First Submitted
March 27, 2020
First Posted
April 2, 2020
Study Start
March 27, 2020
Primary Completion
April 1, 2022
Study Completion
April 1, 2022
Last Updated
January 27, 2021
Record last verified: 2021-01
Data Sharing
- IPD Sharing
- Will not share